Healthcare Bull 3X ETF Direxion (CURE)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.

Phone: 866-476-7523
sethmarcus
sethmarcus Jun. 4 at 1:56 PM
If Insiders are buying Health Care $XLV, you should be too? $AMGN $CURE $IBB $UNH
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy May. 31 at 5:05 AM
21 Best Leveraged Equity ETFs SOXL = Direxion Daily Semiconductor Bull 3X ETF TQQQ - ProShares UltraPro QQQ TECL - Direxion Daily Technology Bull 3X ETF USD - ProShares Ultra Semiconductors QLD - ProShares Ultra QQQ ROM - ProShares Ultra Technology UPRO - ProShares UltraPro S&P500 SPXL - Direxion Daily S&P500 Bull 3X ETF SPUU - Direxion Daily S&P 500 Bull 2X ETF UDOW - ProShares UltraPro Dow30 $SSO - ProShares Ultra S&P500 $CURE - Direxion Daily Healthcare Bull 3X ETF $RXL - ProShares Ultra Health Care $UCC - ProShares Ultra Consumer Discretionary $DDM - ProShares Ultra Dow30 UXI - ProShares Ultra Industrials MIDU - Direxion Daily Mid Cap Bull 3X ETF UMDD - ProShares UltraPro MidCap400 BIB - ProShares Ultra Nasdaq Biotechnology UGE - ProShares Ultra Consumer Staples TNA - Direxion Daily Small Cap Bull 3X ETF https://x.com/MicahMcDonald8/status/2060947289037033584?s=20
0 · Reply
ReadyMate
ReadyMate May. 27 at 1:37 PM
$DTIL $BEAM $CRSP $BMRN $CURE So for Gene Therapy companies, this is a breakthrough and yet another validation: "There has never been a treatment that could directly target and eliminate the root source of hepatitis B viral replication and now there is. " $DTIL announces this huge news and as of the market open it's not even visible on Yahoo Finance. -> Data was presented by was presented by Man Fung Yuen MD, Ph.D., Chair Professor of The University of Hong Kong and Li Shu Fan Medical Foundation Professor in Medicine, and the Chief of the Division of Gastroenterology and Hepatology, Queen Mary Hospital, Hong Kong. He is one of the top internationally renowned researchers in the field of hepatitis B disease. He has now published more than 630 papers in world-renowned medical journals including New England Journal of Medicine, Lancet, Nature Medicine, Lancet Infectious Diseases and Lancet Oncology. He has delivered more than 360 lectures all over the world.
1 · Reply
Dr_Stoxx
Dr_Stoxx May. 19 at 7:12 PM
$XLV / $CURE looking more bullish these days. Always good to look elsewhere when leading sectors are taking a breather. Cycles are good (3 of 4 near lows). Price printing higher lows though in a downtrend. Stochastics earlier buy signal in play. MACD buy signal. Yeah, not bad. Very strong this week...
0 · Reply
deftrades
deftrades Mar. 24 at 1:47 PM
$XLV $CURE started a position here - high quality basket of health care, including Eli Lilly, J&J and Merck. It’s rare to get this at just a 24 RSI, so am taking the discount. Below the 200ma now but still above the bottom bollinger - will DCA on additional weakness.
1 · Reply
Dr_Stoxx
Dr_Stoxx Feb. 18 at 4:08 PM
$CURE: rest day for the breakout champ.
0 · Reply
Dr_Stoxx
Dr_Stoxx Feb. 13 at 2:51 PM
$CURE: safe haven space showing rounded bottom pullback and breakout.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 7:03 PM
$CURE Current Stock Price: $114.91 Contracts to trade: $115.0 CURE Feb 20 2026 Call Entry: $3.10 Exit: $5.95 ROI: 92% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
23ChaseColeman23
23ChaseColeman23 Jan. 17 at 1:11 AM
$DFEN $DUSL $CURE quite the run off of 2025 April lows. Massive. Sidelined in these trading vehicles 🚗
0 · Reply
Helloinvestor123
Helloinvestor123 Jan. 6 at 2:51 PM
$RNAZ other cancer companies trying to short, but will lose their shirt on FDA approval!!! $NVO $CURE $LLY
0 · Reply
Latest News on CURE
Jablonski: Biotech presents a good buying opportunity

Nov 12, 2019, 7:37 AM EST - 7 years ago

Jablonski: Biotech presents a good buying opportunity

LABU XLV

sethmarcus
sethmarcus Jun. 4 at 1:56 PM
If Insiders are buying Health Care $XLV, you should be too? $AMGN $CURE $IBB $UNH
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy May. 31 at 5:05 AM
21 Best Leveraged Equity ETFs SOXL = Direxion Daily Semiconductor Bull 3X ETF TQQQ - ProShares UltraPro QQQ TECL - Direxion Daily Technology Bull 3X ETF USD - ProShares Ultra Semiconductors QLD - ProShares Ultra QQQ ROM - ProShares Ultra Technology UPRO - ProShares UltraPro S&P500 SPXL - Direxion Daily S&P500 Bull 3X ETF SPUU - Direxion Daily S&P 500 Bull 2X ETF UDOW - ProShares UltraPro Dow30 $SSO - ProShares Ultra S&P500 $CURE - Direxion Daily Healthcare Bull 3X ETF $RXL - ProShares Ultra Health Care $UCC - ProShares Ultra Consumer Discretionary $DDM - ProShares Ultra Dow30 UXI - ProShares Ultra Industrials MIDU - Direxion Daily Mid Cap Bull 3X ETF UMDD - ProShares UltraPro MidCap400 BIB - ProShares Ultra Nasdaq Biotechnology UGE - ProShares Ultra Consumer Staples TNA - Direxion Daily Small Cap Bull 3X ETF https://x.com/MicahMcDonald8/status/2060947289037033584?s=20
0 · Reply
ReadyMate
ReadyMate May. 27 at 1:37 PM
$DTIL $BEAM $CRSP $BMRN $CURE So for Gene Therapy companies, this is a breakthrough and yet another validation: "There has never been a treatment that could directly target and eliminate the root source of hepatitis B viral replication and now there is. " $DTIL announces this huge news and as of the market open it's not even visible on Yahoo Finance. -> Data was presented by was presented by Man Fung Yuen MD, Ph.D., Chair Professor of The University of Hong Kong and Li Shu Fan Medical Foundation Professor in Medicine, and the Chief of the Division of Gastroenterology and Hepatology, Queen Mary Hospital, Hong Kong. He is one of the top internationally renowned researchers in the field of hepatitis B disease. He has now published more than 630 papers in world-renowned medical journals including New England Journal of Medicine, Lancet, Nature Medicine, Lancet Infectious Diseases and Lancet Oncology. He has delivered more than 360 lectures all over the world.
1 · Reply
Dr_Stoxx
Dr_Stoxx May. 19 at 7:12 PM
$XLV / $CURE looking more bullish these days. Always good to look elsewhere when leading sectors are taking a breather. Cycles are good (3 of 4 near lows). Price printing higher lows though in a downtrend. Stochastics earlier buy signal in play. MACD buy signal. Yeah, not bad. Very strong this week...
0 · Reply
deftrades
deftrades Mar. 24 at 1:47 PM
$XLV $CURE started a position here - high quality basket of health care, including Eli Lilly, J&J and Merck. It’s rare to get this at just a 24 RSI, so am taking the discount. Below the 200ma now but still above the bottom bollinger - will DCA on additional weakness.
1 · Reply
Dr_Stoxx
Dr_Stoxx Feb. 18 at 4:08 PM
$CURE: rest day for the breakout champ.
0 · Reply
Dr_Stoxx
Dr_Stoxx Feb. 13 at 2:51 PM
$CURE: safe haven space showing rounded bottom pullback and breakout.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 7:03 PM
$CURE Current Stock Price: $114.91 Contracts to trade: $115.0 CURE Feb 20 2026 Call Entry: $3.10 Exit: $5.95 ROI: 92% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
23ChaseColeman23
23ChaseColeman23 Jan. 17 at 1:11 AM
$DFEN $DUSL $CURE quite the run off of 2025 April lows. Massive. Sidelined in these trading vehicles 🚗
0 · Reply
Helloinvestor123
Helloinvestor123 Jan. 6 at 2:51 PM
$RNAZ other cancer companies trying to short, but will lose their shirt on FDA approval!!! $NVO $CURE $LLY
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Jan. 4 at 9:42 PM
16 Leveraged Equity ETFs that don't Suck (yes, all the rest do) 6. $UPRO - ProShares UltraPro S&P500 3X 7. $ROM - ProShares Ultra Technology 2X 8. $SPXL - Direxion Daily S&P 500 Bull 3X Shares 9. $SPUU - Direxion Daily S&P 500 Bull 2X Shares 10. $CURE - Direxion Daily Healthcare Bull 3X Shares Chart dates 6/6/2014 thru 1/2/2026
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 15 at 7:02 PM
$DOCS $CURE $LLY $MRNA leading healthcare today. Just waiting for $UNH to rally to $375+. :-)
0 · Reply
Technomentals
Technomentals Dec. 12 at 7:14 PM
Healthcare exposure turbocharged on Seeking Alpha https://seekingalpha.com/article/4852998-cure-the-leveraged-etf-that-turbocharges-the-leading-us-healthcare-stocks $CURE
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 10 at 8:00 PM
$CURE $GDRX $JNJ $DXCM $UNH Healthcare is nearly all green.
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 3 at 5:12 PM
$UNH Gonna be one of those "just watch and enjoy" days. $HUM $CNC $RXRX $CURE
0 · Reply
Doyoubelieveit
Doyoubelieveit Nov. 19 at 12:29 AM
$TNXP $IYH $CURE
0 · Reply
stocktrader4God
stocktrader4God Nov. 13 at 3:11 AM
$XLV $CURE there are sectors that are much safer than $XLK and $SOXX $SOXL , which are in a tech bubble again like early 2000's.
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Nov. 8 at 5:17 AM
High risk portfolio holdings 11/7/2025 3X HEALTH $CURE GOLD $GLDM CASH $PULS LONG BONDS $EDV 2X INDUSTRIALS $UXI
0 · Reply
23ChaseColeman23
23ChaseColeman23 Nov. 6 at 2:54 AM
$WANT $CURE $NAIL $DUSL $DFEN Looking good into final two months
0 · Reply
savyaz
savyaz Nov. 3 at 6:58 PM
@Rodzilla01 Congratulations on your $CURE Short
1 · Reply